PMID- 26969378 OWN - NLM STAT- MEDLINE DCOM- 20160921 LR - 20211203 IS - 1618-095X (Electronic) IS - 0944-7113 (Linking) VI - 23 IP - 3 DP - 2016 Mar 15 TI - Diosgenin induces ROS-dependent autophagy and cytotoxicity via mTOR signaling pathway in chronic myeloid leukemia cells. PG - 243-52 LID - S0944-7113(16)00028-3 [pii] LID - 10.1016/j.phymed.2016.01.010 [doi] AB - BACKGROUND: Diosgenin, a steroidal saponin isolated from legumes and yams, has been confirmed to possess potent anticancer effect on multifarious tumors including chronic myeloid leukemia (CML). PURPOSE: We aimed to further determine the anti-cancer activity of diosgenin and its mechanisms in CML cells. METHODS: The cell vitality was detected by MTT assay. Autophagic flux and reactive oxygen species (ROS) production were analyzed by laser scanning confocal microscope. Apoptosis was observed by flow cytometry. All proteins expression was examined by western blotting. RESULTS: Autophagy induction was demonstrated by examination of autophagic flux including autophagosomes accumulation, autophagosome-lysosome fusion and degradation of autophagosomes. Moreover, blocking autophagy with inhibitor chloroquine (CQ) and 3-methyladenine (3-MA), enhanced diosgenin-induced apoptosis, indicating the protective effect of autophagy in diosgenin-treated CML cells. Further study suggested that diosgenin-induced autophagy and cytotoxicity were accompanied by reactive oxygen species (ROS) generation and mammalian target of rapamycin (mTOR) signaling pathway inhibition. N-acetyl-L-cysteine (NAC) administration, a scavenger agent of ROS, could down-regulate diosgenin-induced autophagy via reversion of mTOR pathway inhibition. CONCLUSION: These results indicate that diosgenin obviously generates ROS and this oxidative pressure not only produces cytotoxic effect on CML cells but also induces autophagy. What's more, autophagy functions as a cytoprotective mechanism to overcome cytotoxicity of diosgenin in tumor cells and inhibition of autophagy can enhance the anti-CML activity of diosgenin. CI - Copyright (c) 2016 Elsevier GmbH. All rights reserved. FAU - Jiang, Shanshan AU - Jiang S AD - Department of Biosynthesis & Key Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai, China. FAU - Fan, Jiajun AU - Fan J AD - Department of Biosynthesis & Key Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai, China. FAU - Wang, Qian AU - Wang Q AD - Department of Biosynthesis & Key Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai, China. FAU - Ju, Dianwen AU - Ju D AD - Department of Biosynthesis & Key Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai, China. FAU - Feng, Meiqing AU - Feng M AD - Department of Biosynthesis & Key Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai, China. FAU - Li, Jiyang AU - Li J AD - Department of Biosynthesis & Key Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai, China. FAU - Guan, Zhong-Bin AU - Guan ZB AD - Shanghai Institute For Food And Drug Control, Shanghai, China. FAU - An, Duopeng AU - An D AD - Department of Biosynthesis & Key Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai, China. FAU - Wang, Xin AU - Wang X AD - Department of Biosynthesis & Key Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai, China. FAU - Ye, Li AU - Ye L AD - Department of Biosynthesis & Key Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai, China. Electronic address: yelil@fudan.edu.cn. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20160209 PL - Germany TA - Phytomedicine JT - Phytomedicine : international journal of phytotherapy and phytopharmacology JID - 9438794 RN - 0 (Antineoplastic Agents, Phytogenic) RN - 0 (Reactive Oxygen Species) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - K49P2K8WLX (Diosgenin) SB - IM MH - Animals MH - Antineoplastic Agents, Phytogenic/pharmacology MH - Apoptosis/drug effects MH - Autophagy/*drug effects MH - Cell Line, Tumor MH - Diosgenin/*pharmacology MH - Humans MH - Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*pathology MH - Mice MH - Reactive Oxygen Species/*metabolism MH - Signal Transduction/*drug effects MH - TOR Serine-Threonine Kinases/*metabolism OTO - NOTNLM OT - Autophagy OT - Chronic myeloid leukemia OT - Cytotoxicity OT - Diosgenin OT - Reactive oxygen species EDAT- 2016/03/13 06:00 MHDA- 2016/09/23 06:00 CRDT- 2016/03/13 06:00 PHST- 2015/12/07 00:00 [received] PHST- 2016/01/18 00:00 [revised] PHST- 2016/01/26 00:00 [accepted] PHST- 2016/03/13 06:00 [entrez] PHST- 2016/03/13 06:00 [pubmed] PHST- 2016/09/23 06:00 [medline] AID - S0944-7113(16)00028-3 [pii] AID - 10.1016/j.phymed.2016.01.010 [doi] PST - ppublish SO - Phytomedicine. 2016 Mar 15;23(3):243-52. doi: 10.1016/j.phymed.2016.01.010. Epub 2016 Feb 9.